Piefer Awarded Honors by UW

Founder and CEO Greg Piefer has received the University of Wisconsin-Madison Department of Physics’ 2019 Distinguished Alumni Award.  The award is the highest honor presented to accomplished graduates of UW-Madison for their professional achievements, contributions to society and support of the university.

September 12, 2019|

Harrie Buurlage joins SHINE

SHINE Medical Technologies LLC today announced the appointment of Harrie Buurlage as vice president, European operations. Mr. Buurlage will oversee all of SHINE’s activities in Europe, including the company’s siting, construction and operation of a medical isotope production facility there.

September 4, 2019|

$15-million DOE/NNSA award for medical isotope

SHINE Medical Technologies LLC today announced it has received a $15-million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA). The award was made by the agency as part of its effort to establish a reliable, U.S.-produced supply of molybdenum-99 (Mo-99), the most commonly used medical isotope.

August 9, 2019|

Team Exceeds Heart Walk Goal

SHINE Medical Technologies LLC today announced that its team for the annual Bert Blain Memorial Heart Walk in Janesville last weekend exceeded its fundraising goal by 40 percent. The SHINE team’s goal was $6,000 and it raised more than $8,400 to support the American Heart Association’s mission of reducing disability and death caused by heart disease and stroke.

September 3, 2019|

SHINE files application with NRC

SHINE Medical Technologies LLC today announced that the company has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes, including molybdenum-99 (Mo-99), iodine-131 and xenon-133, at its production facility in Janesville, WI. SHINE broke ground on the facility in May of this year.

July 22, 2019|
Go to Top